Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2015-12-21 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Notice under Section 708A(5)(e) of the Corporations Act 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 22 December 2015 regarding a notice under Section 708A(5)(e) of the Corporations Act. It informs about the issuance of shares without disclosure and compliance with relevant provisions, which is a regulatory compliance notice related to capital raising. The document is short (1761 characters) and serves as a formal notification rather than a detailed financial report or presentation. It does not contain financial statements or substantive financial data, nor is it a report or detailed analysis. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to share issuance and capital raising activities.
2015-12-21 English
Admedus announces US$5M Placement of shares 2 pages 237.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement by Admedus Limited about completing a private placement of shares to raise approximately US$5 million. It details the use of funds, the placement terms, and some company background. There are no financial statements or detailed financial performance data included. The document is primarily an update on a capital raising event, not a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5,266 characters, which is consistent with an announcement rather than a full report.
2015-12-21 English
Trading Halt 2 pages 434.8KB
Capital/Financing Update Classification · 95% confidence The document is a market release dated 18 December 2015 from Admedus Limited requesting a trading halt on its securities pending an announcement regarding a proposed material capital raising. The text explicitly states the purpose is to halt trading until a capital raising announcement is made. There are no financial statements, detailed financial data, or report contents included. The document is short (1955 characters) and serves as an announcement of a trading halt related to capital raising, not the capital raising details themselves. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2015-12-17 English
Appendix 3B - Placement 14 pages 795.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. The text includes detailed information about the class and number of securities issued, issue price, purpose of the issue, and compliance with ASX listing rules. It is not a financial report, earnings release, or management discussion but rather a formal announcement of a capital raising event and securities issuance. The document is lengthy (15,000 characters) and contains detailed regulatory disclosures specific to securities issuance and quotation. Therefore, it fits the category of Capital/Financing Update (CAP).
2015-12-17 English
Appendix 3B 15 pages 1.2MB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX) by Admedus Ltd. It details the issuance of shares and options, including the number of securities issued, issue prices, and the purpose of the issue. The document includes references to shareholder approvals at the Annual General Meeting (AGM) and compliance with ASX listing rules. The content is focused on the announcement of new share and option issues and the application for quotation of these securities on the ASX. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of capital changes and securities issuance. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a full regulatory announcement of share issuance.
2015-12-10 English
Change of Director's Interest Notice 12 pages 456.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in directors' relevant interests in securities, including the number of shares held before and after the change, nature of the interest, and consideration paid. The document is a formal notification of personal share transactions by company directors. It is not a financial report, earnings release, or management discussion, but a regulatory disclosure of insider trades. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is substantial and contains detailed transaction data, confirming it is the report itself, not just an announcement or certification. Therefore, the correct classification is DIRS.
2015-12-10 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.